Carlsmed Inc (NAS:CARL)
$ 13.8 +0.11 (+0.8%) Market Cap: 376.78 Mil Enterprise Value: 309.47 Mil PE Ratio: 0 PB Ratio: 4.45 GF Score: 12/100

Q1 2026 Carlsmed Inc Earnings Call Transcript

May 05, 2026 / 08:30PM GMT
Release Date Price: $8.92 (-1.87%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Carlsmed first-quarter 2026 earnings conference call. (Operator Instructions)

I would now like to turn the conference over to your first speaker today, Stephanie Zhadkevich.

Stephanie Zhadkevich
Carlsmed Inc - Vice President, Head of Investor Relations

Thank you, operator. Welcome to Carlsmed's first-quarter 2026 earnings call. Joining me on today's call are Mike Cordonnier, Chairman and Chief Executive Officer; and Leo Greenstein, Chief Financial Officer. Before we begin, I would like to caution that comments made during this call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the market in which Carlsmed operates, trends, expectations, and demand for Carlsmed's products, expectations with respect to reimbursement, statements about the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot